Shilpa Medicare Ltd

Shilpa Medicare Q3 FY2026: Revenue Jumps 32.1% Standalone, 28.3% Consolidated 📈

• Standalone revenue from operations for Q3 FY2026 was ₹16,570.47 lakhs, up 32.1% from ₹12,538.66 lakhs in Q3 FY2025.

• Consolidated revenue from operations for Q3 FY2026 was ₹40,972.67 lakhs, up 28.3% from ₹31,930.12 lakhs in Q3 FY2025.

• Standalone net profit for Q3 FY2026 was ₹1,593.46 lakhs.

• Consolidated net profit attributable to owners was ₹4,458.22 lakhs.

• Exceptional items impacted results with a net loss of ₹220.26 lakhs in standalone Q3 FY2026 due to impairment provisions and gratuity liability.

• A 1:1 bonus share issue was approved and allotted in October 2025, increasing paid-up equity share capital to ₹1,955.82 lakhs.

• The company settled a legal dispute with Celltrion Inc. for ₹2,909.77 lakhs, recognized as an exceptional item in prior periods.